Pfizer – Gene and Gene-modified Cell Therapies Medical Education
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: Wednesday 25th, January 2023
External Deadline: Monday 30th, January 2023
Description
| This Request for Proposals (RFP) is for initiatives that span multiple rare disease areas. The American Society of Gene + Cell Therapy and Pfizer Global Medical Grants are collaborating to offer a new competitive grant opportunity focused on supporting independent medical education to increase the medical and scientific understanding of gene and gene-modified cell therapies.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program. |
Additional details can be found here.
| Date RFP Issued: November 22, 2022
Geographic Scope: Global Clinical Area: Gene Therapy – Rare Disease Link to full RFP: Gene and Gene-modified Cell Therapies Medical Education Application Due Date: January 30, 2023 Specific Area of Interest: Projects that will be considered for support will focus on independent medical education initiatives that will result in the measurable improvement of the medical and scientific understanding of gene and gene-modified cell therapies to help prepare multidisciplinary teams for the integration of gene and gene-modified cell therapies into the treatment armamentarium of eligible patients with a Rare Disease. |